Centessa Pharmaceuticals (CNTA) Gets a Buy from Guggenheim

Tip Ranks
2025.11.18 12:06
portai
I'm PortAI, I can summarize articles.

Guggenheim maintains a Buy rating on Centessa Pharmaceuticals with a $43.00 price target. The stock closed at $27.32, with a Strong Buy consensus and a $37.10 average price target, indicating a 35.80% upside. Wells Fargo also maintains a Buy rating with a $35.00 target.

In a report released yesterday, from Guggenheim maintained a Buy rating on Centessa Pharmaceuticals, with a price target of $43.00. The company’s shares closed yesterday at $27.32.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Centessa Pharmaceuticals with a $37.10 average price target, implying a 35.80% upside from current levels. In a report released on November 13, Wells Fargo also maintained a Buy rating on the stock with a $35.00 price target.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.